- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
TCR diversity – a universal cancer immunotherapy biomarker? ; volume:4 ; number:1 ; day:15 ; month:11 ; year:2016 ; pages:1-4 ; date:12.2016
Journal for ImmunoTherapy of Cancer ; 4, Heft 1 (15.11.2016), 1-4, 12.2016
- Urheber
-
McNeel, Douglas G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40425-016-0175-4
- URN
-
urn:nbn:de:1111-2016112024065
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- McNeel, Douglas G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
TCR-like antibodies in cancer immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
TCR engineered T cells for solid tumor immunotherapy
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Genetic and environmental determinants of human TCR repertoire diversity
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
TcR
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma
TCR-like antibodies in cancer immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
TCR engineered T cells for solid tumor immunotherapy
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Genetic and environmental determinants of human TCR repertoire diversity
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
TcR
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
Validation and promise of a TCR mimic antibody for cancer immunotherapy of hepatocellular carcinoma
TCR-like antibodies in cancer immunotherapy
Next-Generation TCR-transgenic T cells for Immunotherapy
TCR engineered T cells for solid tumor immunotherapy
RNAi-mediated knockdown of the endogenous TCR improves safety of immunotherapy with TCR gene-modified T cells
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Neoantigen-specific TCR-T cell-based immunotherapy for acute myeloid leukemia
Genetic and environmental determinants of human TCR repertoire diversity
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy
TcR
Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy